v3.25.0.1
Stock-based Compensation (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Stock-based Compensation    
Schedule of stock-based compensation expense

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

2024

2023

2024

2023

Sales and marketing

$

4

$

30

$

19

$

89

General and administrative

13

128

83

384

Research and development

15

58

67

183

Total stock-based compensation expense

$

32

$

216

$

169

$

656

Year Ended

December 31, 

    

2023

    

2022

Sales and marketing

$

107

$

280

General and administrative

451

1,494

Research and development

209

313

Total stock-based compensation expense

$

767

$

2,087

Summary of stock option activity

    

Weighted

Weighted

Average

Aggregate

Average

Remaining

Intrinsic

    

Exercise Price

Contractual

Value

Shares

Per Share

Life (years)

(in thousands)

Outstanding at December 31, 2023

 

263

$

21,909.50

$

Options granted

 

Options exercised

 

Options cancelled

 

(105)

7,629.90

Outstanding at September 30, 2024

 

158

$

31,381.48

6.10

$

Exercisable at September 30, 2024

144

$

34,101.10

5.97

$

Vested and expected to vest at September 30, 2024

158

$

31,381.48

6.10

$

 
Summary of unvested RSUs award activity

Weighted

Average

    

Grant Date

Shares

Fair Value

Unvested RSUs at December 31, 2023

 

25

$

7,505.04

Granted

 

Vested (1)

 

(17)

$

(9,333.94)

Cancelled/Forfeited

 

Non-vested RSUs at September 30, 2024

 

8

$

3,847.14

(1)At September 30, 2024, there were 2 shares of common stock related to RSU awards that had vested and the shares were not distributed to the participants.

Weighted

Average

    

Grant Date

Shares

Fair Value

Unvested RSUs at December 31, 2021

591

$

12,644.00

Granted

566

981.36

Vested(1)

(865)

(5,651.52)

Cancelled/Forfeited

(213)

(11,013.04)

Unvested RSUs at December 31, 2022

 

79

10,100.70

Granted

 

Vested(1)

 

(54)

(11,298.98)

Cancelled/Forfeited

 

Non-vested RSUs at December 31, 2023

 

25

$

7,505.04

(1)At December 31, 2023 and 2022, there were 2 and 5 shares of common stock, respectively, related to RSU awards that have vested and the shares were not released to the participants subsequently. Additionally, during the year ended December 31, 2023 due to a decline in our stock price 8 shares of common stock were not issued in order to cover employee taxes.
Summary of assumptions used to estimate grant date fair value of stock options granted  

Risk-free interest rate

    

2.67

%

Expected term (in years)

6.25

Expected dividend yield

0

%

Expected volatility

80.40

%

2003 Stock Incentive Plan, as amended and restated    
Stock-based Compensation    
Summary of stock option activity  

    

Weighted

Weighted

Average

Aggregate

Average

Remaining

Intrinsic

    

Exercise Price

Contractual

Value

Shares

Per Share

    

Life (years)

    

(in thousands)

Outstanding at December 31, 2021

306

$

23,117.06

$

Options granted

194

3,422.00

Options exercised

Options cancelled

(130)

8,071.28

Outstanding at December 31, 2022

 

370

18,075.70

$

Options granted

 

Options exercised

 

Options cancelled

 

(107)

8,661.72

Outstanding at December 31, 2023

 

263

21,909.50

6.4

$

Exercisable at December 31, 2023

213

25,839.58

6.0

Vested and expected to vest at December 31, 2023

274

21,909.50

6.4